These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 8321867)

  • 21. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune mechanisms in vitiligo.
    Bystryn JC
    Immunol Ser; 1989; 46():447-73. PubMed ID: 2488866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
    Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanocyte destruction and repopulation in vitiligo.
    Norris DA; Horikawa T; Morelli JG
    Pigment Cell Res; 1994 Aug; 7(4):193-203. PubMed ID: 7855062
    [No Abstract]   [Full Text] [Related]  

  • 25. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
    Garbelli S; Mantovani S; Palermo B; Giachino C
    Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoid Stress Surveillance Response Contributes to Vitiligo Pathogenesis.
    Raam L; Kaleviste E; Šunina M; Vaher H; Saare M; Prans E; Pihlap M; Abram K; Karelson M; Peterson P; Rebane A; Kisand K; Kingo K
    Front Immunol; 2018; 9():2707. PubMed ID: 30515176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of non-melanocytic skin cells in vitiligo.
    Bastonini E; Bellei B; Filoni A; Kovacs D; Iacovelli P; Picardo M
    Exp Dermatol; 2019 Jun; 28(6):667-673. PubMed ID: 30582762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysfunction of Autophagy: A Possible Mechanism Involved in the Pathogenesis of Vitiligo by Breaking the Redox Balance of Melanocytes.
    Qiao Z; Wang X; Xiang L; Zhang C
    Oxid Med Cell Longev; 2016; 2016():3401570. PubMed ID: 28018522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dilated rough endoplasmic reticulum and premature death in melanocytes cultured from the vitiligo mouse.
    Boissy RE; Beato KE; Nordlund JJ
    Am J Pathol; 1991 Jun; 138(6):1511-25. PubMed ID: 2053597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo.
    Lee AY; Kim NH; Choi WI; Youm YH
    J Invest Dermatol; 2005 May; 124(5):976-83. PubMed ID: 15854039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
    Boukhedouni N; Martins C; Darrigade AS; Drullion C; Rambert J; Barrault C; Garnier J; Jacquemin C; Thiolat D; Lucchese F; Morel F; Ezzedine K; Taieb A; Bernard FX; Seneschal J; Boniface K
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin.
    Le Poole IC; Stennett LS; Bonish BK; Dee L; Robinson JK; Hernandez C; Hann SK; Nickoloff BJ
    Br J Dermatol; 2003 Oct; 149(4):739-48. PubMed ID: 14616364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.
    Le Poole IC; Boissy RE; Sarangarajan R; Chen J; Forristal JJ; Sheth P; Westerhof W; Babcock G; Das PK; Saelinger CB
    In Vitro Cell Dev Biol Anim; 2000 May; 36(5):309-19. PubMed ID: 10937834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo.
    Dell'anna ML; Picardo M
    Pigment Cell Res; 2006 Oct; 19(5):406-11. PubMed ID: 16965269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitiligo.
    Le Poole C; Boissy RE
    Semin Cutan Med Surg; 1997 Mar; 16(1):3-14. PubMed ID: 9125760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitiligo: Pathogenesis, clinical variants and treatment approaches.
    Iannella G; Greco A; Didona D; Didona B; Granata G; Manno A; Pasquariello B; Magliulo G
    Autoimmun Rev; 2016 Apr; 15(4):335-43. PubMed ID: 26724277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients.
    Boissy RE; Liu YY; Medrano EE; Nordlund JJ
    J Invest Dermatol; 1991 Sep; 97(3):395-404. PubMed ID: 1875040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Langerhans' cells in hair follicles of the depigmenting C57Bl/Ler-vit.vit mouse. A model for human vitiligo.
    Palkowski MR; Nordlund ML; Rheins LA; Nordlund JJ
    Arch Dermatol; 1987 Aug; 123(8):1022-8. PubMed ID: 2443080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo.
    Wang X; Erf GF
    J Autoimmun; 2004 Feb; 22(1):21-30. PubMed ID: 14709410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.